Understanding Muscle Spasticity
Muscle spasticity is a condition marked by involuntary muscle stiffness, tightness, and sudden spasms caused by disrupted communication between the brain, spinal cord, and muscles. It commonly occurs in people living with neurological conditions such as Multiple Sclerosis, Cerebral Palsy, Stroke, and Spinal Cord Injury. These abnormal contractions can range from mild stiffness to painful spasms that interfere with mobility and daily life. As patients and healthcare providers explore new ways to manage symptoms, medical cannabis for muscle spasticity relief has gained increasing attention. Research suggests that cannabinoids such as THC and CBD may help reduce muscle spasms and improve symptom management for some patients when traditional treatments are not fully effective (National Academies of Sciences, Engineering, and Medicine, 2017; Koppel et al., 2014).
What Causes Muscle Spasticity?
Muscle spasticity occurs when damage to the brain or spinal cord disrupts the signals that control muscle movement, causing muscles to contract involuntarily or remain abnormally tight. In a healthy nervous system, the brain and spinal cord send balanced signals that tell muscles when to contract and relax. When neurological injuries or diseases interfere with these pathways, the signals can become overactive or misdirected, leading to muscle stiffness, sudden spasms, and exaggerated reflexes. Conditions such as Multiple Sclerosis, Stroke, and Spinal Cord Injury commonly damage the nerve pathways responsible for muscle coordination, which can result in reduced mobility, discomfort, and difficulty performing everyday movements.
The Endocannabinoid System and Muscle Control
The endocannabinoid system (ECS) is a biological signaling network that helps regulate functions such as pain, inflammation, nerve signaling, and muscle control. It consists of endocannabinoids produced by the body, cannabinoid receptors, and enzymes that break these compounds down. Two key receptors are CB1 receptors, found mainly in the brain and central nervous system, and CB2 receptors, which are more common in immune cells and peripheral tissues. Because CB1 receptors are concentrated in areas of the brain and spinal cord involved in movement, the ECS may help regulate muscle tone and involuntary contractions associated with muscle spasticity.
Cannabinoids found in cannabis, particularly THC (tetrahydrocannabinol) and CBD (cannabidiol), interact with the ECS in different ways. THC binds to CB1 receptors in the nervous system and may help relax muscles and reduce abnormal nerve signaling that contributes to spasms. CBD influences ECS activity and other receptors linked to inflammation and nerve communication.
Scientific Research on Cannabis and Spasticity
Over the past two decades, researchers have increasingly studied medical cannabis for muscle spasticity relief, particularly in people with neurological conditions such as Multiple Sclerosis. Spasticity is one of the most common and disabling symptoms of MS, making it a major focus of cannabis-related clinical research. Several randomized controlled trials have examined how cannabinoids, especially THC and CBD, affect muscle stiffness, spasms, and pain. A comprehensive review by the National Academies of Sciences, Engineering, and Medicine concluded that there is substantial evidence that cannabis or cannabinoids can improve patient-reported symptoms of spasticity in multiple sclerosis (National Academies, 2017).
Clinical studies of cannabis-based medicines have also shown promising results. For example, nabiximols, a THC and CBD-based oral spray, has been found to help some patients experience reduced muscle stiffness, fewer spasms, improved sleep quality, and lower pain levels compared with placebo treatments (Collin et al., 2010). However, researchers note that more long-term studies are needed to better understand optimal dosing, long-term safety, and which patients may benefit most from cannabis-based treatments for muscle spasms and neurological spasticity.
Cannabinoids That May Help Reduce Spasticity
Several cannabinoids found in cannabis may help support muscle spasticity relief by interacting with the body’s endocannabinoid system. The most commonly studied include:
THC (Tetrahydrocannabinol)
- Primary psychoactive compound in cannabis
- Activates CB1 receptors in the nervous system
- May help relax muscles and reduce involuntary spasms
CBD (Cannabidiol)
- Non-intoxicating cannabinoid
- Associated with anti-inflammatory and neuroprotective effects
- May help regulate pain, inflammation, and nerve signaling linked to muscle stiffness
THC and CBD Combination
- Often studied together for stronger therapeutic effects
- Known as the “entourage effect”
- Commonly researched for muscle stiffness, chronic spasms, and neurological spasticity
Research continues to explore how these cannabinoids may help manage muscle spasms and spasticity symptoms, particularly in conditions such as Multiple Sclerosis (Russo, 2011; National Institutes of Health).
Learn More: What Is THCA and How Is It Different from THC?
Consumption Methods for Spasticity Relief
People exploring medical cannabis for muscle spasticity relief can choose from several consumption methods, each offering different onset times and durations of effects. Inhalation methods, such as smoking or vaporizing cannabis, provide the fastest onset because cannabinoids enter the bloodstream through the lungs and may offer quicker relief from muscle spasms and stiffness. Edibles and capsules take longer to take effect but often produce longer-lasting symptom relief, which some patients find helpful for nighttime spasticity or persistent discomfort. Tinctures and cannabis oils taken sublingually under the tongue allow for more controlled dosing and relatively quick absorption. Because responses can vary, healthcare professionals often recommend starting with low doses and adjusting gradually when using cannabis for muscle spasms or neurological spasticity (MacCallum & Russo, 2018; National Institutes of Health).
Safety, Considerations, and Future Outlook
While research suggests that medical cannabis for muscle spasticity relief may benefit some individuals, it is important to consider safety and proper dosing. Cannabis can cause side effects such as drowsiness, dizziness, dry mouth, or temporary cognitive changes, particularly with higher levels of THC. Because individual responses vary, experts recommend starting with low doses and consulting a healthcare professional when considering cannabis for muscle spasms or neurological spasticity. Ongoing scientific studies continue to explore the long-term safety and effectiveness of cannabinoids for treating muscle stiffness, chronic spasms, and neurological disorders (National Academies of Sciences, Engineering, and Medicine, 2017; World Health Organization).
Learn More: Cannabis & the Muscular System
References
- National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids. https://nap.nationalacademies.org/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids
- National Multiple Sclerosis Society – Cannabis and MS Spasticity Research. https://www.nationalmssociety.org
- Koppel, B. S., et al. (2014). Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders. American Academy of Neurology. https://n.neurology.org/content/82/17/1556
- Pandyan, A. D., et al. (2005). Spasticity: Clinical Perceptions, Neurological Realities and Meaningful Measurement. https://pubmed.ncbi.nlm.nih.gov/15774331
- National Institute of Neurological Disorders and Stroke – Spasticity Information Page. https://www.ninds.nih.gov/health-information/disorders/spasticity
- Lu, H. C., & Mackie, K. (2016). An Introduction to the Endogenous Cannabinoid System. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789136
- Pertwee, R. G. (2006). Cannabinoid Pharmacology: The First 66 Years. https://pubmed.ncbi.nlm.nih.gov/16596789
- National Institutes of Health – Endocannabinoid System Overview. https://www.ncbi.nlm.nih.gov
- Collin, C., et al. (2010). A Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols in Multiple Sclerosis Spasticity. https://pubmed.ncbi.nlm.nih.gov/20498455
- Russo, E. B. (2011). Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946
- National Institutes of Health – Cannabinoid Research. https://www.nih.gov
- MacCallum, C. A., & Russo, E. B. (2018). Practical Considerations in Medical Cannabis Administration and Dosing. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553
- World Health Organization – Cannabidiol (CBD) Critical Review Report. https://www.who.int

